Early Career Travel Stipend Award

Travel stipends are awarded annually to as many as four pediatric hematology/oncology fellows who have submitted high-quality abstracts as determined by the Conference Planning Committee. Stipend winners are expected to present their abstracts during platform sessions at the ASPHO Conference.

The qualifications for the award candidates are as follows:

• The applicant is either currently a fellow in a pediatric hematology/oncology program or is within 4 years of completing a standard three-year pediatric hematology-oncology fellowship
• The individual’s abstract has been accepted for presentation either as a poster or platform session at the ASPHO meeting
• Author submits an application for funding
• Currently a member of ASPHO living in the United States or Canada
• Applicant has not received any other ASPHO awards this year

To apply, please include the following:

• A supporting letter from the training program director or the program chair, attesting to the applicant’s status as well as his/her role in the conduct of the research project
• In regard to awards for a particular topic, the letter should address the individual’s interest in this area and how participation will advance this area of their career

Winners are chosen based on eligibility criteria, topic, and abstract ranking. The award consists of $500 and will be presented at the conference.

Notes:

• Abstract must be submitted by January 9, 2018
• All application materials must be received no later than January 9, 2018
• Each year approximately 3 awards will be selected based on topical areas of interest as determined by participant needs and/or directed donations
• Selected by the Conference Planning Committee

To Apply for an Award

• Carefully review the criteria for the award to determine eligibility
• Complete the Application Form
• Include required supplemental materials to make your award application complete

2018 Early Career Travel Stipend Award Recipients  

Amy Houghtelin, MD, Children’s National Medical Center, Washington, DC
Ex Vivo Expanded Multi-Antigen Specific Lymphocytes for the Treatment of Solid Tumors

Zachary LeBlanc, MD, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA
Paneth Cell Counts Independently Predict Acute Gastrointestinal GVHD Stage and Response to Therapy

Joseph H. Oved, MD MA, Children’s Hospital of Philadelphia, Philadelphia, PA
Outcomes of Unrelated Donor Peripheral Stem Cell Transplantation for Patients with Non-malignant Hematologic Disorders using Two Partial T Cell Depletion Strategies

Allison Remiker, MD, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Mechanisms Linking Fibrin (Oben) Structure/Function to Tumor Metastasis

Luke R. Smart, MD, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Geospatial Mapping of Sickle Cell Disease in Northwestern Tanzania